CQ 07001
Alternative Names: CQ07-001Latest Information Update: 16 Jul 2016
At a glance
- Originator TNO
- Developer Clinquest Group; TNO
- Class Anti-inflammatories; Biological proteins
- Mechanism of Action Toll-like receptor 3 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Autoimmune disorders; Inflammation; Tissue degeneration
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Autoimmune-disorders in Netherlands (Parenteral)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Inflammation in Netherlands (Parenteral)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Tissue-degeneration in Netherlands (Parenteral)